Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Oct 7;138(14):1206-1207.
doi: 10.1182/blood.2021013362.

COVID-19 and VITT: same or different?

Gowthami M Arepally  1
Affiliations
Editorial

COVID-19 and VITT: same or different?

Gowthami M Arepally. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: G.M.A. serves as a consultant for AstraZeneca and Novartis.

Figures

None
Antibodies to SARS-CoV-2 in COVID-19 and VITT show no overlap.
See this image and copyright information in PMC

Comment on

  • Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A, Selleng K, Mayerle J, Palankar R, Wesche J, Reiche S, Aebischer A, Warkentin TE, Muenchhoff M, Hellmuth JC, Keppler OT, Duerschmied D, Lother A, Rieg S, Gawaz MP, Mueller KAL, Scheer CS, Napp M, Hahnenkamp K, Lucchese G, Vogelgesang A, Flöel A, Lovreglio P, Stufano A, Marschalek R, Thiele T; Immune-Response in COVID-19 Vaccination Study Group. Greinacher A, et al. Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938. Blood. 2021. PMID: 34280256 Free PMC article.

References

    1. Greinacher A, Selleng K, Mayerle J, et al. . Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021;138(14):1269-1277. - PMC - PubMed
    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. - PMC - PubMed
    1. Garcia-Beltran WF, Lam EC, Astudillo MG, et al. . COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184(2):476-488.e11. - PMC - PubMed
    1. Kollias A, Kyriakoulis KG, Lagou S, Kontopantelis E, Stergiou GS, Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis [published online ahead of print 4 April 2021]. Vasc Med. doi:10.1177/1358863X21995566. - DOI - PMC - PubMed
    1. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384(22):2092-2101. - PMC - PubMed